Concepedia

Author

Shengkai Liao

Vertex Pharmaceuticals (United States)

Also Known As

Liao, Shengkai, S.-W. Liao, Shengkai Liao

7

Publications

330

Citations

6

H-Index

27

Concepts

All Affiliations

Vertex Pharmaceuticals (United States)
SL

About

Shengkai Liao is an author at Vertex Pharmaceuticals (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

214

2

Biochemistry

2

2

127

3

Engineering

1

1

47

4

Natural Sciences

1

1

80

5

Allergy

1

1

87

Shengkai Liao

×

5

Publications

324

Citations

5

H-Index

YearCitations

In Vitro and In Vivo Isotope Effects with Hepatitis C Protease Inhibitors: Enhanced Plasma Exposure of Deuterated Telaprevir versus Telaprevir in Rats

François Maltais, Young Chun Jung, Minzhang Chen,

Journal of Medicinal Chemistry

2009

97

Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases

Luc J. Farmer, Mark W. Ledeboer, Thomas Hoock,

Journal of Medicinal Chemistry

2015

87

Second-Generation Antibacterial Benzimidazole Ureas: Discovery of a Preclinical Candidate with Reduced Metabolic Liability

Anne‐Laure Grillot, Arnaud LeTiran, Dean Shannon,

Journal of Medicinal Chemistry

2014

80

Analysis of 8-oxo-7,8-dihydro-2′-deoxyguanosine by ultra high pressure liquid chromatography–heat assisted electrospray ionization–tandem mass spectrometry

Gunnar Boysen, Leonard B. Collins, Shengkai Liao,

Journal of Chromatography B

2009

47

High‐throughput screening for glutathione conjugates using stable‐isotope labeling and negative electrospray ionization precursor‐ion mass spectrometry

Shengkai Liao, Nigel Ewing, Brian Boucher,

Rapid Communications in Mass Spectrometry

2012

13

Page 1